J-Hope, a member of the renowned K-pop boyband BTS celebrated his 31st birthday on February 18, 2025. On his special day, J-Hope, also known as Hobi, celebrated by giving away 200 million KRW to the ...

The newest member in the J Pod of the Southern Resident killer whales, calf J62, has been confirmed as a female by the Center ...

Explore the history and legacy of the TWA terminal, once a symbol of the 'Golden Age of Flying' and now an abandoned landmark ...

America's defence secretary Pete Hegseth said it is 'not realistic' to think Ukraine will return to its pre-2014 borders.

LiSA's “ANOTHER GREAT DAY NORTH AMERICA HEADLINE SHOWS 2025” HEADS OVERSEAS, POWERED BY CRUNCHYROLL The Pop Sensation, Known for Demon Slayer: Kimetsu no Yaiba's “Gurenge, W ...

BTS member J-Hope performed at Le Gala des Pièces Jaunes, a charity event in Paris held by France’s first lady Brigitte Macron. The singer showcased two solo tracks, “On the Street” and ...

While the company's earnings beat was driven by its Innovative Medicines unit, mainly due to its multiple myeloma therapy, Darzalex, according to Bloomberg data on sales consensus, JNJ's MedTech ...

The Food and Drug Administration (FDA) approved Johnson & Johnson’s ketamine-derived nasal spray to help millions of U.S. patients suffering from severe depression. Spravato, approved as a ...

About 21 million U.S. adults in 2021 experienced at least one depressive episodes, latest government data shows. J&J said that about a third of adults will not respond to oral antidepressants alone.

Credit: Justin Paget via Getty Images. Johnson & Johnson’s (J&J) nasal spray Spravato (esketamine) has received a label expansion, now approved as a monotherapy treatment for major depressive disorder ...

With an FDA nod on Tuesday, Johnson & Johnson’s esketamine nasal spray Spravato became the industry’s first monotherapy approved for use in adults with treatment-resistant depression. The approval ...